Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmedeo Afp Regulatory News (AA4)

  • This share is currently suspended. It was suspended at a price of 72.40

Share Price Information for Amedeo Afp (AA4)

Share Price is delayed by 15 minutes
Get Live Data
72.40    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.00 (1.389%)
Market Cap: £188.59m
AA4 Live PriceLast checked at - London Stock Exchange

Intraday Amedeo Afp Share Chart

Director Declaration

16 Jan 2020 17:27

RNS Number : 0900A
Amedeo Air Four Plus Limited
16 January 2020
 

16 January 2020

 

AMEDEO AIR FOUR PLUS LIMITED (the "Company")

(a closed-ended investment company incorporated in Guernsey with registration number 59675) LEI 21380056PDNOTWERG107

 

DIRECTOR DECLARATION

In accordance with the requirements of the Listing Rule 9.6.14R, the Company advises the following change to directorships in other publicly quoted companies, held by the following member of the Board:

John R Le Prevost retired from the Boards of Doric Nimrod Air One Limited, Doric Nimrod Air Two Limited and Doric Nimrod Air Three Limited on 16 January 2020.

 

 

Enquiries:

Company Secretary

JTC Fund Solutions (Guernsey) Limited

Ground Floor

Dorey Court

Admiral Park

St Peter Port

Guernsey GY1 2HT

 

END OF ANNOUNCEMENT

 

E&OE - in transmission

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RDNBFMRTMTTBBAM
Date   Source Headline
1st May 20251:46 pmRNSFACTSHEET
2nd Apr 202510:42 amRNSDividend Declaration
18th Mar 20251:30 pmRNSHolding(s) in Company
5th Mar 202512:55 pmRNSAA4P Beta (MSN164) Redelivery Condition
12th Feb 20257:00 amRNSFactsheet
31st Jan 20257:00 amRNSCompletion of Compulsory Redemption of Shares
23rd Jan 20257:00 amRNSCompulsory Redemption of Shares
16th Jan 20252:24 pmRNSHolding(s) in Company
14th Jan 20254:18 pmRNSAA4P Alpha (MSN157) Redelivery Condition
9th Jan 20253:29 pmRNSDividend Declaration
19th Dec 20247:00 amRNSHalf-year Report
6th Dec 20241:32 pmRNSResult of AGM
15th Nov 20247:00 amRNSNotice of AGM
6th Nov 20247:00 amRNSFactsheet
3rd Oct 20247:00 amRNSDividend Declaration
9th Aug 20247:00 amRNSFactsheet
26th Jul 20247:00 amRNSAnnual Financial Report
2nd Jul 20247:00 amRNSDividend Declaration
13th Jun 20247:00 amRNSHolding(s) in Company
22nd May 20241:43 pmRNSHolding(s) in Company
8th May 20247:00 amRNSFactsheet
2nd May 202412:04 pmRNSHolding(s) in Company
1st May 20247:00 amRNSDirectorate Change
2nd Apr 202410:57 amRNSDividend Declaration
28th Mar 20249:21 amRNSDirectorate Change
13th Feb 20247:00 amRNSFactsheet
11th Jan 20241:56 pmRNSDividend Declaration
20th Dec 20237:00 amRNSHalf-year Report
8th Dec 20234:30 pmRNSResult of AGM
20th Nov 20237:00 amRNSNotice of AGM
16th Nov 20232:24 pmRNSHolding(s) in Company
19th Oct 20237:00 amRNSFACTSHEET
3rd Oct 20237:00 amRNSDividend Declaration
11th Aug 20237:00 amRNSFactsheet and Investor Call
31st Jul 20237:00 amRNSAnnual Financial Report
24th Jul 20235:08 pmRNSDirector/PDMR Shareholding
24th Jul 20235:08 pmRNSDirector/PDMR Shareholding
3rd Jul 202311:17 amRNSDividend Declaration
24th May 20236:03 pmRNSHolding(s) in Company
3rd May 20237:00 amRNSFactsheet
4th Apr 20237:00 amRNSDividend Declaration
1st Mar 20237:00 amRNSCompletion Partial Compulsory Redemption & TVR
22nd Feb 20239:05 amRNSSecond Price Monitoring Extn
22nd Feb 20239:00 amRNSPrice Monitoring Extension
22nd Feb 20237:01 amRNSReturn of Capital and Increased Quarterly Dividend
22nd Feb 20237:00 amRNSFactsheet
19th Jan 20237:00 amRNSDirectorate Change
13th Jan 20234:46 pmRNSHolding(s) in Company
5th Jan 20237:00 amRNSDividend Declaration
14th Dec 20227:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.